Summary
Sébastien Wieckowski is a strategic R&D leader and hybrid scientist with a PhD in immunology and eight years of focused industry experience advancing immuno-oncology and vaccine platforms. Currently Chief Scientific Officer at VAXIMM and founder of consultancy second scight, he bridges translational science, nonclinical development, and data-driven decision making across European and Asian partnerships. He has led IND-enabling programs, complex CRO/CDMO networks, and personalized neoantigen vaccine projects, combining hands-on immunomonitoring and bioassay development with regulatory strategy for EMA, FDA and China filings. Known for pairing deep wet-lab expertise (flow cytometry, PK/PD, GLP toxicology) with bioinformatics and machine-learning informed neoantigen assembly, he accelerates projects from discovery to clinic. A practical collaborator who has steered programs at Roche, Ludwig Cancer Research and startups, he routinely translates academic innovation into GMP-ready assays and regulatory dossiers. Based in Basel, he brings a rare blend of bench-to-boardroom fluency and independent consulting that spotlights underused data perspectives to de-risk development programs.
8 years of coding experience
11 years of employment as a software developer
Master Degree Health Biology/Biochemistry, Master Degree Health Biology/Biochemistry at University of Montpellier
Ph.D. Immunology, Ph.D. Immunology at University of Strasbourg
Baccalauréat Scientifique Spécialité Mathématiques, Baccalauréat Scientifique Spécialité Mathématiques at Lycée Emmanuel d'Alzon, Nîmes
French, English, Polish, German